Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
CyPath Lung
product9 mentionslast seen Oct 29, 2026
Noninvasive diagnostic test for early detection of lung cancer using flow cytometry and artificial intelligence to identify malignant cell populations in sputum.
Relationships 12
- bioAffinity Technologies, Inc.developsCyPath Lung99% confidence9 sources
- CyPath Lungdepends onflow cytometry99% confidence8 sources
- CyPath Lungdepends onartificial intelligence99% confidence8 sources
- CyPath Lungconforms toClinical Laboratory Improvement Amendments99% confidence6 sources
- Precision Pathology Laboratory ServicescommercializesCyPath Lung99% confidence3 sources
- CyPath Lungapplies tolung cancer detection99% confidence3 sources
- CyPath Lungapplies toearly-stage lung cancer detection99% confidence2 sources
- CyPath Lungapplies tolung cancer early detection99% confidence2 sources
- CyPath Lungapplies tolung cancer screening94% confidence1 source
- CyPath Lungdepends onfluorescent porphyrin TCPP92% confidence1 source
- CyPath Lungapplies tolung cancer screening and diagnosis88% confidence1 source
- CyPath Lungapplies toAsian lung cancer market80% confidence1 source
Relationship
bioAffinity Technologies, Inc.developsCyPath Lung
99% confidence9 supporting mentions
Either name opens that entity’s relationships.
Sources 9
- filingSEC EDGAROct 29, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company addressing the need for early lung cancer detection with its noninvasive CyPath ® Lung test
- filingSEC EDGAROct 15, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease
- filingSEC EDGAROct 13, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
CyPath Lung by bioAffinity Technologies is a noninvasive test
- filingSEC EDGAROct 9, 2026bioAffinity Technologies, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc. a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease
- filingSEC EDGAROct 8, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer
- filingSEC EDGAROct 6, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease, today announced that sales of its CyPath® Lung test
- filingSEC EDGARSep 30, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc. , a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease
- filingSEC EDGARSep 22, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company developing noninvasive healthcare solutions
- filingSEC EDGARSep 17, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies is a biotechnology company developing noninvasive healthcare solutions